Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline includes Lenzetto, Evamist, Testosterone Topical Solution, and others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    36

Stocks News & Analysis

stocks

Weekly Earnings Wrap: CBA, CSL, MQG and more

Everything you need to know on last weeks earnings results
stocks

ASX player rallies on small guidance upgrade

Our fair value is maintained despite investor enthusiasm.
stocks

After earnings, is Alphabet stock a buy, a sell, or fairly valued?

With strong fourth-quarter earnings and AI integration, here’s what we think of Alphabet stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,138.8066.60-0.72%
CAC 408,300.1440.42-0.48%
DAX 4024,881.3728.680.12%
Dow JONES (US)49,451.98669.42-1.34%
FTSE 10010,390.2712.17-0.12%
HKSE26,567.12465.42-1.72%
NASDAQ22,597.15469.32-2.03%
Nikkei 22556,941.97697.87-1.21%
NZX 50 Index13,198.18333.30-2.46%
S&P 5006,832.760.000.00%
S&P/ASX 2008,917.6055.30-0.62%
SSE Composite Index4,082.0751.95-1.26%

Market Movers